• No results found

Interferon-β

Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study

Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study

... during interferon-β vary from ...to interferon-β [32, ...with interferon (15,589€), and the combined treatment with both interferon and glatiramer acetate (21,539€) ...the ...

9

Erratum to: Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB

Erratum to: Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB

... adapter-inducing interferon- β (TRIF) deficiency attenuates microglial inflammatory factor ...showing interferon (IFN)- β mRNA expressed in the control, and at 12, 24, and 36 hours in WT and ...

5

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

... murine interferon- β resulted in (days 9 to 17 group) or trended towards (days 9 to 33 group), a greater amelioration of clinical signs of EAE, compared to either treatment alone or to vehicle ...with ...

7

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

... A number of CPE assays have been developed using a variety of cell lines and viruses to determine the titer of an IFN sample. The addition of neutralizing antibodies to the interferon allows the titer of ...

8

Long-term Outcome of Schilder Disease Treated With Interferon-β

Long-term Outcome of Schilder Disease Treated With Interferon-β

... response of tumefactive lesions to corticosteroid is not satisfactory. Intravenous immunoglobulins have also been used more or less successfully as a rescue therapy. 2,21 There have been scarce data regarding DMT for ...

7

In vitro inhibition of monkeypox virus production and spread by Interferon β

In vitro inhibition of monkeypox virus production and spread by Interferon β

... RESEARCH Open Access In vitro inhibition of monkeypox virus production and spread by Interferon b Sara C Johnston1*, Kenny L Lin1, John H Connor3, Gordon Ruthel2, Arthur Goff1 and Lisa E Hensley1 Abst[.] ...

15

Interferon β attenuates lung inflammation following experimental subarachnoid hemorrhage

Interferon β attenuates lung inflammation following experimental subarachnoid hemorrhage

... IFN: interferon; MIP: macrophage inflammatory protein; MPO: myeloperoxidase; MV: mechanical ventilation; NPE: neurogenic pulmonary oedema; RT: reverse transcriptase; SAH: subarachnoid hemorrhage; VCAM: vascular ...

6

Arthritis suppression by NADPH activation operates through an interferon-β pathway

Arthritis suppression by NADPH activation operates through an interferon-β pathway

... Ifn β was increased after injection with ...Ifn β in DA rats at day 10 after treatment with phytol, RNA samples produced from all four separate experiments was analyzed for Ifn α and Ifn β expression ...

19

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS

... After 2 years, the benefits of alemtuzumab vs SC IFN- b -1a were even more appar- ent, with significantly better outcomes emerging both in treatment-naive patients and in those with an i[r] ...

10

An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production In KERTr Cells

An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production In KERTr Cells

... Hitherto, our studies have shown that the azaphenothiazine derivative, DQT, exerts an immunosuppressive effect in in vivo models of delayed-type hypersensitivity to ovalbumin, carrageenan-induced footpad inflammation [9] ...

10

Interferon β for treatment of rheumatoid arthritis?

Interferon β for treatment of rheumatoid arthritis?

... IFNs are a family of naturally secreted proteins with immunomodulatory functions. They enhance the ability of macrophages to destroy tumour cells, viruses and bacte- ria. The IFNs are divided into two types. Type 1 IFNs ...

7

Promyelocytic leukemia protein isoform II promotes transcription factor recruitment to activate interferon β and interferon responsive gene expression

Promyelocytic leukemia protein isoform II promotes transcription factor recruitment to activate interferon β and interferon responsive gene expression

... Depletion of PML-II reduces IFN- ␤ expression. In order to in- vestigate the function of PML-II in interferon expression, we first established conditions for transient knockdown of PML-II using previously ...

14

Pathogenic Effects of IFIT2 and Interferon β during Fatal Systemic Candida albicans Infection

Pathogenic Effects of IFIT2 and Interferon β during Fatal Systemic Candida albicans Infection

... Pathogenic Effects of IFIT2 and Interferon � during Fatal Systemic Candida albicans Infection Marcin Stawowczyk,a Shamoon Naseem,a Valeria Montoya,a Darren P Baker,b* James Konopka,a Nancy C Reicha aD[.] ...

17

Schweninger, Christian
  

(2012):


	Die Rolle von zytosolischer DNA in der Pathogenese des Diabetes mellitus Typ 1.


Dissertation, LMU München: Medizinische Fakultät

Schweninger, Christian (2012): Die Rolle von zytosolischer DNA in der Pathogenese des Diabetes mellitus Typ 1. Dissertation, LMU München: Medizinische Fakultät

... 81 die mRNA-Expression des TLR3-Gens ließ sich durch diese Stimulantien etwas anheben, während sich die der TLR7- und TLR9-Gene kaum haben beeinflussen lassen. Diese Erkenntnisse könnten wieder ein Hinweis darauf sein, ...

113

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

... as interferon gamma (IFN γ) and interleukin (IL)-17 by CD4 + T cells [22], which promote the disruption of blood–brain barrier in- tegrity, allowing egress of activated T cells into the central nervous system ...

11

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

... These findings suggest that double-stranded RNAs are gen- erated in SARS-CoV-infected macrophages. Double-stranded RNA is a potent inducer of IFN- ␤ , triggering cell signaling pathways such as those mediated through ...

8

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

... an interferon response, STATs are ini- tially phosphorylated and IFNα signaling is initiated and re- solved quickly, but during chronic inflammation STATs lose their phosphorylation status even in the presence of ...

10

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

... administration as opposed to intramuscular administra- tion [8,13,14], the dose treatment [7,11] and the different follow-up durations. Moreover, a positive NAb status may be reversible over time [12,13,15]. The origin ...

9

The clinical potential of blood-proteomics in multiple sclerosis

The clinical potential of blood-proteomics in multiple sclerosis

... In the first case, the differentially expressed proteins were: Rho-GDI2, Rab GDIβ (Rab2) and Cofilin 1. In the second case, the differentially expressed proteins were: Cortactin and the Fibrinogen β Chain ...

8

The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention

The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention

... once activated – namely a phagocytic phenotype (innate activation) or the aforementioned antigen-presenting phenotype (adaptive activation) that is seen post TBI. When challenged with certain pathogen-associated mo- ...

8

Show all 10000 documents...

Related subjects